Artículos por temáticas

Spasticity, gait, and balance in patients with multiple sclerosis: A cross-sectional study

Norbye AD, Midgard R, Thrane G.

Physiother Res Int. 2020 Jan;25(1):e1799. doi: 10.1002/pri.1799. Epub 2019 Jul 9.

[Intermittent theta-burst transcranial magnetic stimulation for the treatment of spasticity in patients with recurring multiple sclerosis: the results of a double-blind randomised clinical trial].

Dieguez-Varela C, Lion-Vazquez S, Fraga-Bau A, Rodriguez-Acevedo B, Rodriguez-Sanchez L, Collazo-Dieguez M, Pereira-Martinez MN, Salgado-Barreira A, Alvarez-Rodriguez E, Vicente-Alba P, Munoz D, Ferna

Rev Neurol. 2019 Jul 16;69(2):45-52. doi: 10.33588/rn.6902.2018275. Spanish.

Phenol Neurolysis for Management of Focal Spasticity in the Distal Upper Extremity

Karri J, Zhang B, Li S.

PM R. 2020 Mar;12(3):246-250. doi: 10.1002/pmrj.12217. Epub 2019 Sep 10.

Late recovery of responsiveness after intra-thecal baclofen pump implantation and the role of diffuse pain and severe spasticity: a case report.

Formisano R, Aloisi M, Contrada M, Spanedda F, Schiattone S, Niedbala S, Cobianchi MR, Baldeschi GC, Buzzi MG.

Acta Neurochir (Wien). 2019 Sep;161(9):1965-1967. doi: 10.1007/s00701-019-03994-2. Epub 2019 Jul 3.

Prevalence of unmet needs for spasticity management in care home residents in the East Midlands, United Kingdom: a cross-sectional observational study.

Edwards L, Ellis B, Donnellan C, Osman H, Haboubi N, Jones M, Sunman W, Pinnington L, Phillips MF.

Clin Rehabil. 2019 Jul 2:269215519859621. doi: 10.1177/0269215519859621. [Epub ahead of print]

Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis.

Marvulli R, Megna M, Citraro A, Vacca E, Napolitano M, Gallo G, Fiore P, Ianieri G.

Toxins (Basel). 2019 Jul 1;11(7). pii: E381. doi: 10.3390/toxins11070381.

The effect of cycling using active-passive trainers on spasticity, cardiovascular fitness, function and quality of life in people with moderate to severe Multiple Sclerosis (MS); a feasibility study.

Barclay A, Paul L, MacFarlane N, McFadyen AK.

Mult Scler Relat Disord. 2019 Sep;34:128-134. doi: 10.1016/j.msard.2019.06.019. Epub 2019 Jun 18.

Low-Dose Intrathecal Ziconotide for Spasticity From Primary Lateral Sclerosis: A Case Report.

Zhu X, Kohan LR, Goldstein RB.

A A Pract. 2019 Jul 1;13(1):31-33. doi: 10.1213/XAA.0000000000000978.

Localising movement disorders in childhood.

Bamford NS, McVicar K.

Lancet Child Adolesc Health. 2019 Oct 22. pii: S2352-4642(19)30330-X. doi: 10.1016/S2352-4642(19)30330-X. [Epub ahead of print] Review.

Functional movement disorders

Galli S, Béreau M, Magnin E, Moulin T, Aybek S.

Rev Neurol (Paris). 2020 May;176(4):244-251. doi: 10.1016/j.neurol.2019.08.007. Epub 2019 Oct 9.

A Power Spectral Density-Based Method to Detect Tremor and Tremor Intermittency in Movement Disorders.

Luft F, Sharifi S, Mugge W, Schouten AC, Bour LJ, van Rootselaar AF, Veltink PH, Heida T.

Sensors (Basel). 2019 Oct 4;19(19). pii: E4301. doi: 10.3390/s19194301.

Impaired Action Control in Patients With Functional Movement Disorders

van Wouwe NC, Mohanty D, Lingaiah A, Wylie SA, LaFaver K.

J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):73-78. doi: 10.1176/appi.neuropsych.19030076. Epub 2019 Oct 7.

Functionally meaningful rating scales in progressive pediatric movement disorders

Perlman S.

Dev Med Child Neurol. 2020 Feb;62(2):157. doi: 10.1111/dmcn.14372. Epub 2019 Oct 3.

Deep Brain Stimulation in Movement Disorders: From Experimental Surgery to Evidence-Based Therapy.

Krack P, Volkmann J, Tinkhauser G, Deuschl G.

Mov Disord. 2019 Oct 3. doi: 10.1002/mds.27860. [Epub ahead of print]

Internal Versus External Frame of Reference in Functional Movement Disorders

Vizcarra JA, Hacker S, Lopez-Castellanos R, Ryes L, Laub HN, Marsili L, Dwivedi AK, LaFaver K, Espay AJ.

J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):67-72. doi: 10.1176/appi.neuropsych.18110290. Epub 2019 Sep 30.